These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31052333)

  • 21. Elevated liver enzymes following open Roux-en-Y gastric bypass for morbid obesity - does timing of liver retraction affect the rise in the levels of transaminases?
    Lohlun JC; Guirguis A; Wise L
    Obes Surg; 2004 Apr; 14(4):505-8. PubMed ID: 15130227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole Absorption and Fasting Gastrinemia After Roux-en-Y Gastric Bypass.
    Collares-Pelizaro RVA; Santos JS; Nonino CB; dos Reis Dias LA; Gaitani CM; Salgado W
    Obes Surg; 2017 Sep; 27(9):2303-2307. PubMed ID: 28397104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
    Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
    JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the biochemical, inflammatory and oxidative profile of obese patients given clinical treatment and bariatric surgery.
    Schmatz R; Bitencourt MR; Patias LD; Beck M; da C Alvarez G; Zanini D; Gutierres JM; Diehl LN; Pereira LB; Leal CA; Duarte MF; Schetinger MR; Morsch VM
    Clin Chim Acta; 2017 Feb; 465():72-79. PubMed ID: 27986549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisional Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Systematic Review of Comparative Outcomes with Respective Primary Procedures.
    Mahawar KK; Graham Y; Carr WR; Jennings N; Schroeder N; Balupuri S; Small PK
    Obes Surg; 2015 Jul; 25(7):1271-80. PubMed ID: 25893649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.
    Ooi GJ; Burton PR; Doyle L; Wentworth JM; Bhathal PS; Sikaris K; Cowley MA; Roberts SK; Kemp W; Earnest A; O'Brien PE; Brown WA
    Obes Surg; 2017 Jun; 27(6):1533-1542. PubMed ID: 27966066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality.
    Reges O; Greenland P; Dicker D; Leibowitz M; Hoshen M; Gofer I; Rasmussen-Torvik LJ; Balicer RD
    JAMA; 2018 Jan; 319(3):279-290. PubMed ID: 29340677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WEIGHT LOSS AND METABOLIC OUTCOMES 12 MONTHS AFTER ROUX-EN-Y GASTRIC BYPASS IN A POPULATION OF SOUTHEASTERN BRAZIL.
    Pinhel MA; Nicoletti CF; de Oliveira BA; Chaves RC; Parreiras LT; Sivieri T; Vulcano VM; Luz GR; Annunciato DR; Morgado LM; Marcatto G; Salgado Junior W; Souza DR; Nonino CB
    Nutr Hosp; 2015 Sep; 32(3):1017-21. PubMed ID: 26319814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bariatric surgery in severely obese adolescents improves major comorbidities including hyperuricemia.
    Oberbach A; Neuhaus J; Inge T; Kirsch K; Schlichting N; Blüher S; Kullnick Y; Kugler J; Baumann S; Till H
    Metabolism; 2014 Feb; 63(2):242-9. PubMed ID: 24332707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ghrelin levels could be involved in the improvement of insulin resistance after bariatric surgery.
    Santiago-Fernández C; García-Serrano S; Tome M; Valdes S; Ocaña-Wilhelmi L; Rodríguez-Cañete A; Tinahones FJ; García-Fuentes E; Garrido-Sánchez L
    Endocrinol Diabetes Nutr; 2017; 64(7):355-362. PubMed ID: 28745606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery.
    Gholam PM; Kotler DP; Flancbaum LJ
    Obes Surg; 2002 Feb; 12(1):49-51. PubMed ID: 11868297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of hepatic steatosis in morbidly obese persons after gastric bypass.
    Silverman EM; Sapala JA; Appelman HD
    Am J Clin Pathol; 1995 Jul; 104(1):23-31. PubMed ID: 7611176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Incidence of Secondary Hyperparathyroidism in Bariatric Patients: Comparing Different Procedures.
    Wei JH; Lee WJ; Chong K; Lee YC; Chen SC; Huang PH; Lin SJ
    Obes Surg; 2018 Mar; 28(3):798-804. PubMed ID: 28921422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial.
    Kraljević M; Delko T; Köstler T; Osto E; Lutz T; Thommen S; Droeser RA; Rothwell L; Oertli D; Zingg U
    Trials; 2017 May; 18(1):226. PubMed ID: 28532499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The influence of bariatric surgery on calcium homeostasis and biochemical markers of bone turnover in patients with morbid obesity].
    Czerwińska E; Marcinowska-Suchowierska E; Walicka M; Lisik W; Wierzbicki Z
    Endokrynol Pol; 2007; 58(2):130-8. PubMed ID: 17578829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury.
    Cho YE; Im EJ; Moon PG; Mezey E; Song BJ; Baek MC
    PLoS One; 2017; 12(2):e0172463. PubMed ID: 28225807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.
    Ballantyne GH
    Obes Surg; 2006 Jun; 16(6):795-803. PubMed ID: 16756746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.
    Yan Y; Zhou Z; Kong F; Feng S; Li X; Sha Y; Zhang G; Liu H; Zhang H; Wang S; Hu C; Zhang X
    Obes Surg; 2016 Nov; 26(11):2683-2690. PubMed ID: 27038047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipocyte Size and Leptin Receptor Expression in Human Subcutaneous Adipose Tissue After Roux-en-Y Gastric Bypass.
    Tamez M; Ramos-Barragan V; Mendoza-Lorenzo P; Arrieta-Joffe P; López-Martínez S; Rojano-Rodríguez ME; Moreno-Portillo M; Frigolet ME
    Obes Surg; 2017 Dec; 27(12):3330-3332. PubMed ID: 28924918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.